-
Milwaukee Landmarks Go Blue for Colorectal Cancer Awareness Month as Cancer Incidence Increases Among Younger Adults
March is National Colorectal Cancer Awareness Month. This year, the observance is receiving increased recognition at the city, county, and state levels through proclamations from Milwaukee Mayor Cavalier Johnson, County Executive David Crowley, and Governor Tony Evers.
-
Medical College of Wisconsin Cancer Center Announces New Training Program to Boost Diversity in Cancer Research
The Medical College of Wisconsin (MCW) Cancer Center today announced a new two-year training program to improve diversity, equity, and inclusion in cancer research.
-
Medical College of Wisconsin Partners with Top Cancer Organizations to Endorse Initiative to Increase Lung Cancer Screening
MCW has partnered with more than 50 cancer organizations to issue a call to action urging individuals, providers and insurers to increase access to and utilization of low-dose computed tomography (CT) scans for those at high risk for lung cancer.
-
Serving Those Who Serve
MCW and the Zablocki VA Medical Center’s 76-year partnership benefits both doctors and patients.
-
Researcher Pilots New Process that Reduces the Length of Cancer Radiation Treatments
Dr. Joseph Zenga is leveraging the power of research to help improve outcomes for his cancer patients.
-
MCW Neurosurgeon-Scientist Seeks to Unlock the Mysteries of the Brain Through Research with Tumors
Dr. Max Krucoff is developing surgical techniques to make tumor removals safer and more complete.
-
Medical College of Wisconsin Celebrates Groundbreaking for New Cancer Research Building
The Medical College of Wisconsin (MCW) ceremoniously broke ground today on the new 150,000-square-foot cancer research building that will play a significant role in mitigating the cancer burden throughout eastern Wisconsin and beyond.
-
Paula & Rodger Riney Foundation Provides $5.9 Million to Accelerate Multiple Myeloma Research
Gift supports research during the next two years at the MCW Cancer Center.
-
The Greg Sensiba Memorial: A Family Inspired to Give Back
To honor Greg and show gratitude for the care he received, the Greg Sensiba Memorial was created.
-
Targeting Tumor and Tumor Microenvironment Vulnerabilities
Drs. Balaraman Kalyanaraman and Gang Cheng from MCW and Dr. Micael Hardy in France have published a review article that posits that mitochondria-targeted drugs combined with standard-of-care chemotherapy, radiation therapy, and immunotherapy are likely to have potentiating effects in cancer treatment.
-
When Prostate Cancer Returns
MCW physician-scientists test new treatment for advanced prostate cancer.
-
Family Inspired to Make a Difference
Loyal. Tough. Fighter. Inviting. Outgoing. Stubborn. Devoted wife. Loving mother.
-
MCW Researcher Awarded US Patent for Mito-Lonidamine Compositions and Methods to Treat Cancer
Dr. Balaraman Kalyanaraman and collaborators at Aix-Marseille Université, France are inventors on MCW’s recently awarded US Patent for Mito-Lonidamine, Compositions and Methods of Use, which pertains to mitochondria-targeting cationic drugs and methods of using them to inhibit lung cancer proliferation and progression and metastasis to the brain.
-
Combinatorial Mitochondria-Targeted Drug Therapy as a Novel Option for Lung Cancer Prevention
Balaraman Kalyanaraman, PhD, chair and professor of biophysics and the Harry R. & Angeline E. Quadracci Professor in Parkinson’s Research, collaborates with researchers from the Houston Methodist Research Institute and Aix-Marseille Université.
-
Melissa Prah Receives Outstanding Presentation Award
Melissa Prah, engineer II in the Schmainda lab in the Department of Biophysics, receives the American Society of Neuroradiology’s 2022 (ASNR22) Outstanding Presentation Award.
-
Medical College of Wisconsin Cancer Center Expands Leadership Team to Advance Cancer Discovery
Appointments demonstrate commitment to lead cancer research, address cancer disparities in Wisconsin and beyond.
-
Innovative Therapy that "Tricks" and Destroys Cancer Cells Advances to Clinical Trial
Results from pre-clinical research show iron-like compound holds promise for treating patients with glioblastoma, an aggressive brain cancer
-
Michels Family and Michels Family Foundation Donates $15 Million for Rare Cancers Research
Gift honors Sophie Michels, a long-term cancer survivor.
-
PEGylated Mitochondria-Targeted Drugs Have Potential in Cancer Treatment
Balaraman Kalyanaraman, PhD, and Gang Cheng, PhD, collaborate with researchers from Aix-Marseille Université and Houston Methodist Research Institute.
-
MCW Researchers Awarded US Patent for Mito-Metformin Compounds and Methods to Treat Cancer
Balaraman Kalyanaraman, PhD, and Jacek Zielonka, PhD, DSc, are two of the inventors on MCW’s recently awarded US Patent for Modified Mito-Metformin Compounds and Methods of Synthesis and Use Thereof.
